US, EU Warn About Birth Defect Risk From Dolutegravir US, EU Warn About Birth Defect Risk From Dolutegravir

The FDA and EMA have warned about a possible increased risk for neural tube defects in infants born to women who take dolutegravir for HIV during pregnancy.News Alerts
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: HIV/AIDS News Alert Source Type: news